Please login to the form below
licencing
This page shows the latest licencing news and features for those working in and with pharma, biotech and healthcare.
Boehringer bolsters NASH pipeline with $870m Yuhan deal
Yuhan said that the combined molecule will be developed using technology licenced from fellow South Korean biotech Genexine, which will be eligible for a 5% of the out-licencing deal in
Latest news
-
AZ invests more in IO with Transgene oncolytic virus deal
Theresearch and licencing agreement centres on AZ developing five engineered oncolytic vaccinia virus candidates with Transgene, which specialises in the field.
-
Time running out for ‘no-deal’ Brexit medicines laws
This will be based on current UK licencing practices, but CAPs manufacturers only have until the 22 April should they decide to opt-out of this.
-
Chiesi's ultra-rare genetic disorder therapy wins European backing
Europe.”. Lamzede, which has been investigated in 33 patients, both adults and children, and the Italian group expects a licencing decision by the European Commission in the second quarter of 2018.
-
Shire licences Parion dry eye drug in $535m deal
Bolsters the Irish group's ophthalmic portfolio. Shire has agreed a licencing deal with Parion Sciences for a dry eye disease drug that bolsters its ophthalmic portfolio, a priority area for
-
LEO Pharma picks up AZ skin disease drugs in $1bn deal
Gains rights to eczema and psoriasis treatments
AZ invests more in IO with Transgene oncolytic virus deal
Time running out for ‘no-deal’ Brexit medicines laws
Chiesi's ultra-rare genetic disorder therapy wins European backing
Shire licences Parion dry eye drug in $535m deal
LEO Pharma picks up AZ skin disease drugs in $1bn deal
More from news
Approximately 1 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Akari Therapeutics strengthens board
Grissinger (pictured right) has spent 22 years at Johnson &Johnson, holding positions of vice president and head of worldwide pharmaceutical licencing, as well as vice president and head of worldwide pharmaceutical
Akari Therapeutics strengthens board
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital project manager
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Digital account director
-
Competitive
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Digital strategist
-
Competitive
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- GSK reveals plans for £400m R&D facility expansion in England
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med
- Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
